We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current 0IFR market cap is 21.35M. The company's latest EPS is USD -1.0677 and P/E is -1.24.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 13.92M | 8.88M | 11.25M | 12.91M | 18.28M |
| Operating Income | -16.64M | -13.29M | -14.71M | -15.56M | -15.11M |
| Net Income | -12.13M | -15.83M | -9.76M | -15.08M | -15.2M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 21.92M | 20.6M | 49.17M | 40.9M | 28.92M |
| Total Liabilities | 15.12M | 16.16M | 11.95M | 15.46M | 16.31M |
| Total Equity | 6.8M | 4.43M | 37.22M | 25.44M | 12.61M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -15.77M | -8.76M | -11.16M | -14.69M | -15.72M |
| Investing | -60k | N/A | -59k | -5.18M | -157k |
| Financing | 19.04M | 10.7M | 38.71M | N/A | 348k |
| Market Cap | 21.35M |
| Price to Earnings Ratio | -1.24 |
| Price to Sales Ratio | 1.03 |
| Price to Cash Ratio | 2.83 |
| Price to Book Ratio | 1.49 |
| Dividend Yield | - |
| Shares Outstanding | 14.24M |
| Average Volume (1 week) | 543 |
| Average Volume (1 Month) | 623 |
| 52 Week Change | 0.00% |
| 52 Week High | 1.50 |
| 52 Week Low | 1.50 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Ekso Bionics Holdings Inc |
| Address |
8275 south eastern avenue las vegas, nevada 89123 |
| Website | https://www.eksobionics.com |
| Industry | general indl mach & eq, nec (3569) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
